Front Line Medical Technologies announced the launch in the United Kingdom of its CE Mark-approved COBRA-OS—Control of Bl ...

Venova Medical recently announced the enrollment of the first patients in the company’s VENOS-2 early feasibility study o ...

Concept Medical Inc. announced the completion of patient enrollment in the SirPAD trial of the company’s MagicTouch percu ...

Concept Medical Inc., announced the enrollment of the first patient in the pivotal MAGICAL BTK randomized controlled trial, whi ...

Dr. Suresh Vedantham asks Drs. Pavan Kavali and Kristen Sanfilippo about possible benefits of a DVT response team model, ...

Alan Lumsden, MD Walter W. Fondren III Presidential Distinguished Chair, DeBakey Heart & Vascular Center Chair, Department of ...

The VIVA Foundation, in collaboration with representatives from the American Venous Forum (AVF) and American Vein and ...

In a large, real-world analysis of United States Medicare fee-for-service patients, Ferro et al found that inferior vena cava ...

Moderator Suresh Vedantham, MD, asks Leslie Lake, Volunteer President of the National Blood Clot Alliance and bilateral PE ...

Insights into the digital tools that can help improve patient engagement and advance understanding in deep vein thrombosis ...

The knowns and unknowns about venous thrombus biology as it relates to in-stent restenosis and how these results drive ...

R3 Vascular Inc. recently announced that it received WCG institutional review board (IRB) approval for the ELITE-BTK pivotal tr ...